Suchergebnisse

The relationship between depression, diabetes, and access to diabetes care is es-
tablished in high-income countries (HICs) but not in middle-income countries
(MICs), where contexts and health systems differ and may impact this relation-
ship. In this study, we investigate access to diabetes care for individuals with and
without depressive symptoms in MICs.
We analyzed pooled data from nationally representative household surveys across
Brazil, Chile, China, Indonesia, and Mexico. Validated survey tools Center for Epidemio-
logic Studies Depression Scale Revised, Composite International Diagnostic Interview,
Short Form, and Patient Health Questionnaire identified participants with depressive
symptoms. Diabetes, defined per World Health Organization Package of Essential Non-
communicable Disease Interventions guidelines, included self-reported medication use
and biochemical data. The primary focus was on tracking diabetes care progression
through the stages of diagnosis, treatment, and glycemic control. Descriptive and mul-
tivariable logistic regression analyses, accounting for gender, age, education, and BMI,
examined diabetes prevalence and care continuum progression.
The pooled sample included 18,301 individuals aged 50 years and above; 3,309
(18.1%) had diabetes, and 3,934 (21.5%) exhibited depressive symptoms. Diabe-
tes prevalence was insignificantly higher among those with depressive symptoms
(28.9%) compared with those without (23.8%, P = 0.071). Co-occurrence of diabe-
tes and depression was associated with increased odds of diabetes detection
(odds ratio [OR] 1.398, P < 0.001) and treatment (OR 1.344, P < 0.001), but not
with higher odds of glycemic control (OR 0.913, P = 0.377).
In MICs, individuals aged 50 years and older with diabetes and depression showed height-
ened diabetes identification and treatment probabilities, unlike patterns seen in HICs.
This underscores the unique interplay of these conditions in different income settings.